Is there a role for retinoids to treat minimal residual disease in neuroblastoma?

British Journal of Cancer

Volumn 83, Issue 9, 2000, Pages 1121-1123

  Matthay, K K ^a,b   Reynolds, C P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; ISOTRETINOIN; RETINOIC ACID; RETINOID;

CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; HUMAN; NEUROBLASTOMA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE;

EID: 0033754111     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1430     Document Type: Review

References (30)

1. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells
2. A phase I pharmacokinetic study of fenretinide (HPR) in children with high-risk solid tumors. A Children's Cancer Group (CCG) study
3. Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer
4. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide
5. Long-term effects of fenretinide on retinal function
6. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid
7. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide
8. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the Childrens Cancer Study Group
9. Five-year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations
10. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines
11. Drug resistance patterns in human neuroblastoma cell lines derived from patients at different phases of therapy
12. N-(4-hydroxyphenyl)retinamide: A potent inducer of apoptosis in human neuroblastoma cells
13. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Childrens Cancer Group pilot study
14. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
15. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
16. Modulators of ceramide metabolism syngergize fenretinide cytotoxicity in multiple tumor cell types
17. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines
18. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: Apoptosis versus differentiation
19. Retinoid therapy of neuroblastoma
20. Response of neuroblastoma to retinoic acid in vitro and in vivo
21. Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines
22. N-(4-hydroxyphenyl-retinamide is highly active against retinoic acid resistant neuroblastoma cell lines
23. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma
24. Retinoic acid induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro
25. Retinoic acid-induced differentiation of human neuroblastoma: A cell variant system showing two distinct responses
26. Retinoids in cancer therapy
27. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
28. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
29. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation
30. The effect of tamoxifen and fenretinide on human colorectal cancer cell lines in vitro